SLOAN GAIL A 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Jan 4, 2010
Insider Transaction Report
Form 4
SLOAN GAIL A
VP of Finance
Transactions
- Award
Restricted Stock Units
2009-12-31+483,810→ 483,810 total→ Common Stock (483,810 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of La Jolla Pharmaceutical Company common stock; award date value of common stock was $0.158 per share (the average of the closing prices of La Jolla Pharmaceutical Company's common stock for the five trading days following December 22, 2009).
- [F2]The restricted stock units vest upon the closing of La Jolla Pharmaceutical Company's proposed merger with Adamis Pharmaceuticals Corporation, subject to the continued employment of the reporting person through the closing date of the merger.